ArticleTherapeutic advances in neurological disorders2022

Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination.

Simon Faissner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.